Trending Topic

20 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Article highlights There is growing clinical importance attributed to the development of metabolic dysfunction-associated steatotic liver disease in people with type 2 diabetes (T2D). Numerous international groups now advocate screening for advanced fibrosis in people with risk factors, such as T2D, using non-invasive biomarkers. This article explores the rationale to screen for advanced fibrosis in people with risk […]

3 mins

Carol Levy, DTM 2022: Benefits of insulin pump in people living with type 2 diabetes

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 24th 2022

Insulin pumps are electronic devices that help you stabilise your blood glucose levels and control your diabetes. Control-IQ technology could be a powerful management solution for therapy needs of individuals living with type 2 diabetes. In this touchENDOCRINOLOGY interview, Prof. Carol Levy (Icahn School of Medicine at Mount Sinai, New York City, NY, USA) discusses the benefits of insulin pump people in people living with type 2 diabetes and gives a brief overview of the t:slim X2 insulin pump with Control-IQ technology.

The abstract entitled: ‘Significant Reduction in Hyperglycemia and High Satisfaction with Use of Control-IQ Technology in Prior MDI and Basal-Only Insulin Users with Type 2 Diabetes was presented at the 22nd Annual Diabetes Technology Meeting, 03-05 Nov, 2022.

Questions:

  1. What are the benefits of insulin pump in people living with type 2 diabetes? (0:22)
  2. Could you give us a brief overview of the t:slim X2 insulin pump with Control-IQ technology? (1:35)

Disclosures: Carol Levy is a consultant for Dexcom and Eli Lilly and discloses grant/research support from Abbott Diabetes, Insulet and Tandem. 

Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.

Recorded as a highlight of DTM 2022

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup